Text Size

Automated Telephone Outreach With Speech Recognition to Improve Diabetes Care: A Randomized Controlled Study (ATO-SR-DM)

This study has been completed.
Sponsor:
Collaborator:
American Diabetes Association
Information provided by:
Harvard Pilgrim Health Care
ClinicalTrials.gov Identifier:
NCT00790530
First received: November 11, 2008
Last updated: NA
Last verified: November 2008
History: No changes posted
  Purpose

The purpose of this study is to evaluate the effectiveness of automated telephone outreach with speech recognition to improve diabetes care.


Condition Intervention
Diabetes Mellitus
 Behavioral: Automated Telephone Outreach with Speech Recognition
Other: Usual Care

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Open Label
Primary Purpose: Health Services Research
Official Title: Automated Telephone Outreach With Speech Recognition to Improve Diabetes Care: A Randomized Controlled Study

Resource links provided by NLM:

MedlinePlus related topics: Diabetes
U.S. FDA Resources

Further study details as provided by Harvard Pilgrim Health Care:

Primary Outcome Measures:
  • Completion of dilated eye examination [ Time Frame: 12-months following intervention ] [ Designated as safety issue: No ]

Secondary Outcome Measures:
  • Completion of glycated hemoglobin testing (HbA1c) [ Time Frame: one-year following intervention ] [ Designated as safety issue: No ]
  • Completion of LDL-cholesterol testing [ Time Frame: one year following intervention ] [ Designated as safety issue: No ]
  • Completion of microalbumin testing [ Time Frame: one-year following intervention ] [ Designated as safety issue: No ]

Enrollment: 1200
Study Start Date: June 2006
Study Completion Date: October 2007
Primary Completion Date: October 2007 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: ATO-SR
Automated Telephone Outreach with Speech Recognition
 Behavioral: Automated Telephone Outreach with Speech Recognition
Automated Telephone Outreach with Speech Recognition
No Intervention: Usual Care
Usual Care
 Other: Usual Care
Usual Care

Detailed Description:

Randomly allocate a total of 1200 health plan members with diabetes to automated telephone outreach with speech recognition (ATO-SR; N = 600) or usual care (N = 600). The intervention is a series of three calls, using automated calls, originating from the health plan, using interactive speech recognition technology, spaced approximately 4-6 weeks apart, to encourage participants to fulfill the recommended testing (dilated eye examinations, glycated hemoglobin, LDL-cholesterol, microalbumin) that had not been performed received in the preceding year.

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • Age 18 years or older
  • Diabetes, defined as either 1) filled a prescription for insulin or an oral hypoglycemic agent; or, 2) had two outpatient or one inpatient or two outpatients encounter claims with an ICD9-CM or CPT code indicating diabetes.
  • Gap in a key diabetes management metric as evidenced by no claim for a dilated eye examination in the prior 15 months and no claim for one or more of the following tests: glycated hemoglobin, LDL-cholesterol, or microalbumin. (Individuals with evidence of having received ACE-inhibitors or angiotensin receptor blockers were considered to have had a microalbumin test.)

Exclusion Criteria:

  • No primary care clinician in the data base
  • Those who had previously asked the health plan to exclude them from research or quality improvement
  • Women whose claim records contained diagnoses suggesting gestational diabetes
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00790530

Locations
United States, Massachusetts
Harvard Pilgrim Health Care
Boston, Massachusetts, United States, 02215
Sponsors and Collaborators
Harvard Pilgrim Health Care
American Diabetes Association
Investigators
Principal Investigator: Steven R Simon, MD Harvard Pilgrim Health Care
  More Information

No publications provided by Harvard Pilgrim Health Care

Additional publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):

Responsible Party: Steven R. Simon, Principal Investigator, Harvard Pilgrim Health Care
ClinicalTrials.gov Identifier: NCT00790530     History of Changes
Other Study ID Numbers: 1-05-JF-40
Study First Received: November 11, 2008
Last Updated: November 11, 2008
Health Authority: United States: Institutional Review Board

Keywords provided by Harvard Pilgrim Health Care:
Diabetes
Information Technology
Health Plans

Additional relevant MeSH terms:
Diabetes Mellitus
Glucose Metabolism Disorders
Metabolic Diseases
Endocrine System Diseases

ClinicalTrials.gov processed this record on May 16, 2013